Galatea Bio
Miami Lakes · Founded 2021
About Galatea Bio
Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $28.7M
- Last round: Series Unknown (Mar 2025)
- Website: https://www.galatea.bio/
Industries & Categories
Artificial Intelligence (AI), Big Data, Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/galatea-bio-79952 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.